In the US, Fenoldopam (fenoldopam systemic) is a member of the drug class agents for hypertensive emergencies and is used to treat Hypertensive Emergency and Prevention of Radiographic Contrast Nephropathy.
US matches:
- Fenoldopam
- Fenoldopam Mesylate
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C01CA19
CAS registry number (Chemical Abstracts Service)
0067227-56-9
Chemical Formula
C16-H16-Cl-N-O3
Molecular Weight
305
Therapeutic Categories
Diuretic agent
Antihypertensive agent
Chemical Name
6-Chloro-2,3,4,5-tetrahydro-1-(p-hydroxyphenyl)-1H-3-benzazepine-7,8-diol
Foreign Names
- Fenoldopamum (Latin)
- Fenoldopam (German)
- Fénoldopam (French)
- Fenoldopam (Spanish)
Generic Names
- Fenoldopam (OS: BAN)
- Fénoldopam (OS: DCF)
- SKF 82526 (IS)
- Fenoldopam Mesilate (OS: BAN)
- Fenoldopam Mesylate (OS: USAN)
- SKF 82526-J (IS)
- Fenoldopam Mesylate (PH: USP 32)
Brand Names
- Carlacor
Elan, Luxembourg - Corlopam
Hospira, United States; Cephalon, Italy - Fenoldopam Mesylate
Bedford, United States; PharmaForce, United States; Sandoz, United States
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment